Detection of HPV E7 oncoviral protein in cervical lesions by a new antibody

Applied Immunohistochemistry and Molecular Morphology

Volumn 21, Issue 4, 2013, Pages 341-350

  Faoro, Valentina ^a   Barbazza, Renzo ^a   Bonin, Serena ^a   Brunetti, Davide ^a   Sulfaro, Sandro ^b   Stanta, Giorgio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b S MARIA DEGLI ANGELI HOSPITAL   (Italy)

Author keywords

cervical cancer; E7 oncoviral protein; HPV infection; immunohistochemistry; tissue microarray

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN E7; PROTEIN P53; TELOMERASE REVERSE TRANSCRIPTASE; UBIQUITIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; TISSUE MICROARRAY; UTERINE CERVIX CANCER; WART VIRUS; WESTERN BLOTTING;

ANTIBODIES, VIRAL; BLOTTING, WESTERN; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84880916815     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318269bf5d     Document Type: Article

References (26)

1. Yu L, Wang L, Zhong J, et al. Diagnostic value of p16INK4A, Ki- 67, and human papillomavirus l1 capsid protein immunochemical staining on cell blocks from residual liquid-based gynecologic cytology specimens. Cancer Cytopathol. 2010;118:47-55.
2. Costa C, Espinet B, Molina MA, et al. Analysis of gene status in cervical dysplastic lesions and squamous cell carcinoma using tissue microarrays. Histol Histopathol. 2009;24:821-829.
3. zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer. 2002;2:342-350.
4. zur Hausen H. Papilloma virus infections: A major cause of human cancer. In: Zur Hausen H, ed. Infections Causing Human Cancer. Weinheim: Wiley-VCH; 2006:145-198.
5. Muñoz N, Bosch FX, De Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527.
6. Klaes R. Overexpression of p16(INK4) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276-284.
7. Wang SS. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a populationbased cohort in Costa Rica. Cancer Epidemiol Biomarkers Prev. 2004;13:1355-1360.
8. Mulvany NJ, Allen DG, Wilson SM. Diagnostic utility of p16INK4a: A reappraisal of its use in cervical biopsies. Pathology. 2008;40:335-344.
9. Fortune D, Scurry J. The use of p16INK4a as an adjunct to the interpretation of cervical biopsies. Pathology. 2006;38:190-191.
10. Tsoumpou I, Arbyn M, Kyrgiou M, et al. p16INK4a immunostaining in cytological and histological specimens from the uterine cervix: A systematic review and meta-analysis. Cancer Treat Rev. 2009;35:210-220.
11. Nam EJ, Kim JW, Hong JW, et al. Expression of the p16INK4a and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection. J Gynecol Oncol. 2008;19:162-168.
12. Saha B, Chaiwun B, Tsao-Wei DD, et al. Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions. Int J Gynecol Pathol. 2007;26:214-222. .
13. Jarboe EA, Thompson LC, Heinz D, et al. Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma. Hum Pathol. 2004;35:396-402.
14. Follen M, Schottenfeld D. Surrogate endpoint biomarkers and their modulation in cervical chemoprevention trials. Cancer. 2001;91: 1758-1776.
15. De Méndez Morelva T, Antonio L. Immunohistochemical expression of ubiquitin and telomerase in cervical cancer. Virchows Arch. 2009;455:235-243.
16. Petersen I, Schewe C, Schluns K, et al. Inter-laboratory validation of PCR-based HPV detection in pathology specimens. Virchows Arch. 2007;451:701-716.
17. Faoro V, Stanta G. Rapid protein extraction from FFPE tissues samples. In: Stanta G, ed. Guidelines for Molecular Analysis in Archive Tissues. Heidelberg, Berlin: Springer-Verlag GmbH; 2011: 249-251.
18. Castle PE, Stoler MH, Wright TC Jr., et al. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: A subanalysis of the ATHENA study. Lancet Oncol. 2011;12:880-890.
19. Snijders PJ, Heideman DA, Meijer CJ. Methods for HPV detection in exfoliated cell and tissue specimens. APMIS. 2010;118:520-528.
20. Bodily J, Laimins LA. Persistence of human papillomavirus infection: Keys to malignant progression. Trend Microbiol. 2011;19:33-39.
21. Galgano MT, Castle PE, Atkins KA, et al. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol. 2010;34:1077-1087.
22. Malpica A, Matisic JP, Van Niekirk D, et al. Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: Qualitative histopathologic analysis and methodologic issues. Gynecol Oncol. 2005;99(suppl 3):S38-S52
23. Parker MF, Zahn CM, Vogel KM, et al. Discrepancy in he interpretation of cervical histology by gynecologic pathologists. Obstet Gynecol. 002;100:277-280.
24. Conesa-Zamora P, DomÃrnech-Peris AN, Orantes-Casado FJ, et al. Effect of human papillomavirus on cell cycle 'related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma. Am J Clin Pathol. 2009;132:378-390.
25. Martin CM, O'Leary JJ. Histology of cervical intraepithelial neoplasia and the role of biomarkers. Best Pract Res Clin Obstet Gynaecol. 2011;25:605-615.
26. Carter JR, Ding Z, Rose BR. HPV infection and cervical disease: A review. Aust N Z J Obstet Gynaecol. 2011;51:103-108.